casopitant

This page covers all casopitant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sigma non-opioid intracellular receptor 1, Substance-P receptor.

Targets

Sigma non-opioid intracellular receptor 1, Substance-P receptor

Phase 3 pipeline (1)

• Zunrisa · Neuroscience
  Zunrisa works by blocking the action of Substance-P, a natural substance that can cause nausea and vomiting.

Patent intelligence

• casopitant patent landscape — aggregated cliff calendar, attackable patents, originator estates